Study by Mackowiak et al. (1998) showed alterations in cerebral perfusion, with a focal increase in the basal ganglia after IFN-β, while a decreased level of regional blood perfusion was reported in patients treated for hepatitis with IFN-α (Tanaka et al., 2006). This evidence concerns the gene IFNA17 and Hepatitis.